Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Palliative Oncology: Denosumab
Eric Prommer
Hematology/Oncology
Research output
:
Contribution to journal
›
Article
›
peer-review
5
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Palliative Oncology: Denosumab'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Denosumab
100%
Diphosphonates
58%
Neoplasm Metastasis
43%
Bone and Bones
31%
Radiation
26%
Bisphosphonate-Associated Osteonecrosis of the Jaw
26%
Kyphoplasty
25%
RANK Ligand
23%
Clinical Trials
23%
Cryosurgery
22%
Radiopharmaceuticals
21%
Radiofrequency Ablation
19%
Osteoclasts
18%
Cytoplasmic and Nuclear Receptors
18%
Jaw
18%
United States Food and Drug Administration
17%
Glucocorticoids
16%
Renal Insufficiency
15%
Analgesics
15%
Pharmaceutical Preparations
14%
Economics
13%
Monoclonal Antibodies
13%
Pharmacology
11%
Quality of Life
11%
Pain
10%
Therapeutics
5%
Neoplasms
5%